What is Medis Suite XA?
Medis Suite XA is our all-encompassing solution for X-Ray angiography, leveraging over thirty years of experience in cardiovascular imaging analysis. This extensive package includes a range of modules, such as an intuitive viewer and specialized analyses focused on coronary and vascular evaluations, which facilitate in-depth anatomical assessments of arteries. Additionally, it provides analyses for both left and right ventricles, along with built-in reporting functionalities to streamline the process. The suite offers sophisticated analyses for coronary and peripheral vessels, known as QCA and QVA, as well as left and right ventriculograms, referred to as QLV and QRV. A particularly noteworthy feature is the groundbreaking QFR® analysis, which assesses the functional significance of lesions without the need for adenosine or a pressure wire, enhancing patient comfort. Furthermore, the suite is designed for smooth integration within existing healthcare IT systems, ensuring straightforward connectivity to the DICOM network to optimize workflow efficiency and elevate patient care standards. Overall, Medis Suite XA marks a pivotal development in the realm of cardiovascular imaging technology, setting a new benchmark for diagnostic precision.
Pricing
Free Trial Offered?:
Yes
Integrations
No integrations listed.
Similar Software to Medis Suite XA
Significantly improve the speed and quality of Radiology reporting by reducing unnecessary dictation, particularly for ultrasound and DEXA. Imorgon transfers modality measurements into Powerscribe/Fluency/RadAI merge fields/tokens, eliminating manual entry errors.
Imorgon's specialized services offer the following advantages:
- All measurements are always transferred (usually DICOM SR)
- Electronic worksheets capture findings and insert them into Powerscribe/Fluency/RadAI (rather than dictating from a worksheet)
- Worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- Integrate into Epic or other EHRs
- Vendor neutral
- Support to ensure everything continues working
Significant improvement in the overhead of reporting with a quick ROI.
Learn more
MediRoutes is an innovative cloud-based software solution tailored for the management of Non-Emergency Medical Transportation (NEMT) fleets. This comprehensive platform boasts capabilities such as real-time dispatching, automated scheduling, billing, detailed reporting, and seamless API integrations. Specifically designed for transportation service providers, it promotes effective route planning and offers real-time visibility into fleet operations, alongside integration with payers. By minimizing passenger wait times and enhancing the operational efficiency of NEMT providers, MediRoutes ensures reliability through sophisticated scheduling algorithms. It streamlines the coordination of patient transport and collaborates with all major brokers across the United States, solidifying its position as a leader in the NEMT software landscape since its inception in 2008. Furthermore, its ongoing commitment to innovation allows MediRoutes to continually adapt to the evolving needs of the transportation industry.
Learn more
Artrya
Artrya partners with clinics that focus on patients with chest pain to pioneer advanced AI-driven cardiovascular care models. This collaboration facilitates the integration of high-prognostic value plaque characteristics into the evaluation of coronary artery disease. In both emergency and primary care settings, swift assessments of chest pain patients become achievable. We foresee a future where heart attack occurrences within communities are drastically diminished. By leveraging AI insights from coronary computed tomography angiography (CCTA), healthcare providers can quickly categorize chest pain patients within minutes, based on the type and volume of arterial plaque identified. This innovative technology allows for the prompt detection of individuals with minimal or no coronary artery disease, ensuring that no concealed plaque characteristics are overlooked that could potentially lead to severe cardiac incidents in the future. Identifying early signs of a possible heart attack is of utmost importance. Furthermore, this method enables the effective identification of patients at risk who present with acute or atypical chest pain, guaranteeing they receive appropriate further evaluation and treatment. By adopting this proactive approach, not only are patient outcomes improved, but the overall health of the community is also enhanced, fostering a culture of preventive care. The ongoing commitment to integrating cutting-edge technology will continue to transform cardiovascular care for the better.
Learn more
Infervision
Established in 2016, Infervision is a leader in the realm of AI-powered medical technology, committed to improving healthcare operations and interdisciplinary services with cutting-edge artificial intelligence innovations. Their sophisticated AI solutions are crafted to support healthcare practitioners in a variety of functions, such as disease detection, diagnosis, intervention, treatment, patient management, and medical research. Notable among their products is InferRead CT Lung, which excels at identifying lung nodules in chest CT scans, while InferRead DR Chest is focused on uncovering chest abnormalities through X-ray imaging. Additionally, InferRead CT Coronary is specifically designed to detect coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is proficient in assessing brain hemorrhages via CT scans. The company also features InferRead CT Bone for identifying chest fractures in CT images, along with InferRead CT Pneumonia for diagnosing and managing pneumonia cases effectively. Their offerings extend further with InferOperate, which aids in 3D reconstruction for surgical procedures involving the thoracic, liver, and urological regions, as well as InferCare, a tool that enhances patient management and image follow-up. Furthermore, InferScholar serves as an AI-enhanced platform for advancing medical research, reinforcing Infervision's dedication to revolutionizing healthcare through its AI technology. This extensive collection of solutions firmly establishes Infervision as a crucial contributor to the advancement of modern medical practices, highlighting its role in shaping the future of healthcare delivery.
Learn more
Screenshots and Video
Company Facts
Company Name:
Medis Medical Imaging Systems
Date Founded:
1989
Company Location:
Netherlands
Company Website:
medisimaging.com/medis-suite-xa/
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Online Training
On-Site Training
Video Library
Support
Standard Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English
Medis Suite XA Categories and Features
Radiology Software
Audit Trail
EDI
Image Fusion